Search the Newsreel

GPPL: Strong revenue and profit growth, with key settlements and export incentives boosting results

Avalyn Pharma Inc. Q2 2026: Net loss $(28.9M), EPS $(0.98) — 10-Q Summary

Avalyn Pharma Inc. reported a wider net loss of $(28.9M) in Q2 2026, compared to $(20.2M) in Q2 2025, with basic and diluted net loss per share at $(0.98). The clinical-stage biotech company continues to invest in its development programs, including AP01, AP02, and …

Avalyn Pharma reports Q2 2026 net loss $28.9M; cash $413.5M, runway into 2029

Avalyn Pharma reported a Q2 2026 net loss of $28.9 million, ending the period with $413.5 million in cash, which is projected to fund operations into 2029. The company saw increased R&D and G&A expenses due to clinical activity and headcount. Key business highlights …

Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com

This article reports that Avalyn Pharma Inc. has filed a Form 8K for August 12, as reported by Investing.com. The filing is brief and does not provide further details within the article content. It is categorized under stock market news.

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Avalyn Pharma Inc. announced its financial results for the second quarter ended June 30, 2026, and highlighted recent business achievements, including the completion of enrollment for its MIST global Phase 2b trial of AP01 with 398 patients. The company reported $413.5 million in cash, …

S&P 500 Futures Climb in Premarket Trading; CoreWeave, CAVA Group Lead

S&P 500 futures climbed in premarket trading, with CoreWeave Inc. (CRWV) rising 18.5% and CAVA Group Inc. (CAVA) increasing 11.5%. These movements occurred two hours before the U.S. stock markets were set to open. The article highlights the significant pre-market gains for these two …

Savannah Resources (LSE:SAV) Brings Lithium Financing Back Into Focus

Cava Q2 2026 earnings beat on same-store sales, traffic gains

Cava Group reported second-quarter net income of $23 million, or 19 cents a share, as same-restaurant sales rose 9% and guest traffic climbed 5.3% compared with the same period a year earlier. Revenue for the quarter ended July 12 reached $365.4 million, a 31.3% …

Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Recommendation of "Buy" by Analysts

Five research firms have issued a consensus "Buy" rating for Avalyn Pharma Inc. (NASDAQ:AVLN), with an average 12-month price target of $59.00. The company recently reported a quarterly loss of $21.83 per share, missing analyst estimates, and currently has a market capitalization of $1.57 …

Datavault AI (NASDAQ:DVLT) Upgraded by Zacks Research to Hold Rating

Zacks Research has upgraded Datavault AI (NASDAQ:DVLT) to a "Hold" rating, though analyst sentiment remains mixed, with a consensus "Moderate Buy" rating and a $2.50 average price target. The company's stock opened at $0.31, below its moving averages, and is facing new securities class-action …

CAVA Q2 Earnings: New Store Cohorts Are Outselling the System, Productivity Tops 100%

Jefferies Adjusts Price Target on AvalonBay Communities to $201 From $205, Maintains Hold Rating

Jefferies has lowered its price target for AvalonBay Communities (AVB) to $201 from $205, while maintaining a Hold rating on the stock. This adjustment reflects an updated outlook from the analyst firm. AvalonBay Communities is a real estate investment trust specializing in apartment communities.

CAVA Group (CAVA) grows sales 32% with 476 restaurants and higher traffic

CAVA Group, Inc. reported strong financial results for the quarter and year-to-date periods ended July 12, 2026, with quarterly revenue up 31.3% to $368.4 million and year-to-date revenue up 31.7% to $806.7 million, primarily driven by rapid restaurant expansion and a 9.0% increase in …

Cava Group shares jump as revenue and restaurant traffic beat expectations

Restaurant ©Adobe Stock Images Cava Group Inc (NYSE:CAVA) reported second-quarter revenue above Wall Street forecasts as strong customer traffic and same-restaurant sales helped maintain growth momentum, sending the shares around 10% higher in U.S. premarket trading on Wednesday. The Mediterranean fast-casual restaurant chain posted …

Cava’s investment in value and wages pays off

This story was originally published on Restaurant Dive. To receive daily news and insights, subscribe to our free daily Restaurant Dive newsletter. Dive Brief: Cava posted 9.7% same-store sales growth with a 5.3% bump in traffic in Q2, according to the brand's earnings release. …

Avantium N.V.: Fundamentele analyse en financiële beoordelingen | 0RNP | NL0015002IE0

Avalo Therapeutics, Inc. $AVTX Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC significantly increased its stake in Avalo Therapeutics (NASDAQ:AVTX) by 556.4% in the first quarter, now owning 120,114 shares valued at $1.79 million. Despite this institutional interest, Avalo Therapeutics faces challenging financial prospects with missed earnings expectations and projected future losses. Wall …

JPMorgan upgrades Grupo Aval stock rating on Colombia outlook

Companies & Markets Analysis 12/08/2026: Hill & Smith, ECO Animal Health, Titon Holdings, CLS Holdings, Balfour Beatty, 80 Mile, Atalaya Mining Copper SA, Evoke, Seeing Machines, Kazera Global, Savannah Resources, Alternative Income REIT, Predator

CAVA Group, Inc. Stock 12‑Month Price Target Cut to $91.83, Implies 51% Upside

Analysts have slightly reduced the 12-month average price target for CAVA Group, Inc. stock to $91.83 from $92.77, though this still suggests a 51% potential upside from its August 11 closing price. The consensus rating for CAVA remains a "Buy," with 19 analysts recommending …

Theravance Biopharma (TBPH) Stock Caught Between Fading Gains And Royalty Doubts

Cava Group Inc (CAVA) (Q2 2026) Earnings Call Highlights: Revenue Surges 31. ...

This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cava Group Inc (NYSE:CAVA) reported a 31.3% increase in revenue and a 9% rise in …

SAVARA Q2 EPS USD -0.16

The article reports that Savara (SVRA) announced its Q2 Earnings Per Share (EPS) as USD -0.16. This financial figure indicates the company's profitability during the second quarter.

Savannah Energy Wins Strong Shareholder Backing for Capital and Takeover Flexibility

CRWV, LITE, CAVA, NBIS, SMCI: 5 Trending Stocks Today - CoreWeave (NASDAQ:CRWV)

This article highlights five trending stocks that captured investor attention: CoreWeave, Lumentum Holdings, Cava Group, Nebius Group, and Super Micro Computer. Each company's stock performance and recent earnings reports are detailed, showing how many beat analyst estimates, particularly in revenue and EPS. The article …

Novavax, Inc. (NVAX) Stock Analysis: Growth Potential Amidst A 77% Upside

Novavax, Inc. (NVAX), a biotechnology company specializing in vaccines, shows a promising potential upside of 77.47% according to analyst ratings, despite current financial challenges including a 76.30% revenue decline. The company's strategic partnerships and product pipeline, including Nuvaxovid and the R21 Matrix-M malaria vaccine, …

Kaplan Fox Encourages Investors of Datavault AI Inc. (NASDAQ: DVLT) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT) on behalf of investors who purchased securities between September 4, 2024, and October 30, 2025. The lawsuit alleges that Datavault AI was a "stock promotion" based on …

CAVA reiterates FY2026 outlook for 4.5%-6.5% same-restaurant sales amid food safety-related volatility

Earnings Call Insights: CAVA Group, Inc. (CAVA) Q2 2026 MANAGEMENT VIEW * "Our second quarter results underscore the continued strength of our category-defining brand and the resonance of our value proposition with today's consumer," said Co-Founder, CEO, President & Director Brett Schulman, highlighting "same …

CAVA Group Inc (CAVA) Q2 2026 Earnings Call Transcript

CAVA Group Inc. reported strong Q2 2026 results, with revenue up 31.3%, same-restaurant sales increasing by 9% (driven by 5.3% traffic), and adjusted EBITDA rising 30% to $54.7 million. The company opened 17 net new restaurants, bringing the total to 476, and remains confident …

Cava Group (CAVA) Surpasses Q2 Earnings and Revenue Estimates

Cava Group (CAVA) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Cava Stock Jumps on Foot Traffic Gains

Cava Group stock jumped more than 10% in Tuesday’s after hours trading after the restaurant chain delivered stronger-than-expected second quarter results as customer foot traffic continued to rise. For the quarter ended July 12, Cava’s restaurant revenue increased 31.3% to $365.4 million, leaving total …

Avalonbay Communities Inc. stock underperforms Tuesday when compared to competitors

Avalonbay Communities Inc. (AVB) stock fell 1.13% to $181.76 on Tuesday, underperforming the broader market. This marks the second consecutive day of losses for the company, as the S&P 500 and Dow Jones Industrial Average also experienced declines.

Savannah Goldfields Limited's (ASX:SVG) Shift From Loss To Profit

Savara (NASDAQ:SVRA) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Savara (NASDAQ:SVRA) announced its quarterly earnings, reporting a loss of $0.16 per share, which missed the consensus estimate by $0.02. Shares fell by $0.16 to $5.57 during Tuesday trading. The company maintains a "Moderate Buy" consensus rating from analysts, with an average target price …

CAVA’s (NYSE:CAVA) Q2 CY2026 Sales Beat Estimates, Stock Jumps 10.2%

CAVA's (NYSE:CAVA) Q2 CY2026 Sales Beat Estimates, Stock Jumps 10.2% Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 31.3% year on year to $368.4 million. Its GAAP profit of $0.19 per share was …

CAVA Group surges on revenue beat, robust traffic growth

CAVA Group Inc. (NYSE:CAVA) saw its shares jump 10% in premarket trading after reporting second-quarter results that surpassed revenue expectations. The Mediterranean fast-casual chain demonstrated strong same-restaurant sales and traffic growth, with revenue reaching $365.4 million, exceeding estimates. Despite a slight decrease in restaurant-level …